Tarani Kanta Barman

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 7

Top Topics

Candida Albicans

Staphylococcus Aureus

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

The Journal of antimicrobial chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Tridib Chaira, Chandru Subramani, Tarani Kanta Barman
ADME, Pharmacokinetic Scaling, Pharmacodynamic and Prediction of Human Dose and Regimen of Novel Antiviral Drugs. Pharmaceutics 15 (4) (2023)
Tridib Chaira, Chandru Subramani, Tarani Kanta Barman
ADME, Pharmacokinetic Scaling, Pharmacodynamic and Prediction of Human Dose and Regimen of Novel Antiviral Drugs. Pharmaceutics 15 (4) (2023)
Tridib Chaira, Chandru Subramani, Tarani Kanta Barman
ADME, Pharmacokinetic Scaling, Pharmacodynamic and Prediction of Human Dose and Regimen of Novel Antiviral Drugs. Pharmaceutics 15 (4) (2023)
Tridib Chaira, Chandru Subramani, Tarani Kanta Barman
ADME, Pharmacokinetic Scaling, Pharmacodynamic and Prediction of Human Dose and Regimen of Novel Antiviral Drugs. Pharmaceutics 15 (4) (2023)
Tarani Kanta Barman, Victor C Huber, Jesse L Bonin, Danielle Califano, Sharon L Salmon, Andrew N J McKenzie, Dennis W Metzger
Viral PB1-F2 and host IFN-γ guide ILC2 and T cell activity during influenza virus infection. Proceedings of the National Academy of Sciences of the United States of America 119 (8) (2022)
Tarani Kanta Barman, Dennis W Metzger
Disease Tolerance during Viral-Bacterial Co-Infections. Viruses 13 (12) (2021)
Manoj Kumar, Tarun Mathur, Tarani Kanta Barman, Tridib Chaira, Ram Kumar, Vattan Joshi, Manisha Pandya, Lalima Sharma, Kunihiko Fujii, Mahadev Bandgar, Balasaheb Jadhav, Ramesh Bambal, Dilip Upadhyay, Nobuhisa Masuda, Ashwani Kumar Verma, Pradip Kumar Bhatnagar
Novel FtsZ inhibitor with potent activity against Staphylococcus aureus. The Journal of antimicrobial chemotherapy 76 (11) (2021)